Paul S. Covington

Eluxadoline for Irritable Bowel Syndrome with Diarrhea

Anthony Lembo, Brian E. Lacy, Marc J. Zuckerman et al. · New England Journal of Medicine · 2016 · 318 citations · Full text

Eluxadoline Benefits Patients With Irritable Bowel Syndrome With Diarrhea in a Phase 2 Study

Leonard S. Dove, Anthony Lembo, Charles Randall et al. · Gastroenterology · 2013 · 143 citations · Full text

Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes

Paul S. Covington, Ronald Christopher, Miles P. Davenport et al. · Clinical Therapeutics · 2008 · 136 citations

Diabetes Management, Diabetes, Pharmacology +6

Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects

Ronald Christopher, Paul S. Covington, Miles P. Davenport et al. · Clinical Therapeutics · 2008 · 128 citations

Molecular Pharmacology, Pharmacological Study, Medicine +5

Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients

David Andrae, Donald L. Patrick, Douglas A. Drossman et al. · Health and Quality of Life Outcomes · 2013 · 107 citations · Full text